1) Increased thrombin generation |
Mediated predominantlyby tissue factor/factor VIIa pathway |
2) Impaired function of physiological anticoagulant pathway |
|
a) Reduction of antithrombin levels |
The result of a combination of increased consumption, enzyme degradation, impaired liver synthesis and vascular leakage |
b) Depression of protein C system |
The result of a combination of increased consumption, impaired liver synthesis, vascular leakage and down- regulation of thrombomodulin |
c) Insufficienttissue factor pathway inhibitor (TFPI) |
|
3) Impaired fibrinolysis |
Mediated by release of plasminogen activators from endothelial cells immediately followed by an increase in the plasma levels of plasminogen activator inhibitor type 1 (PAI-1) |
4) Activation of inflammatory pathway |
Mediated by activated coagulation proteins and by depression of the protein C system |